News | April 28, 2026
AstraZeneca wins US nod for at-home lupus treatment in major shift for SLE care
The approval was driven by data from the Phase III TULIP-SC trial
The approval was driven by data from the Phase III TULIP-SC trial
Growth was broad-based across segments
Move to accelerate cancer care expansion across India
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours
The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
The new device promises faster, more efficient cardiac procedures while maintaining the safety and effectiveness clinicians expect
Subscribe To Our Newsletter & Stay Updated
